DEF 14A
Teva Pharmaceutical: What To Expect In 2023 With New CEO (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceuticals Agrees To $85 Million Settlement With Oklahoma In Opioid Case | KPBS Public Media
Teva Reports Second Quarter 2021 Financial Results | Business Wire
Teva Pharmaceutical Industries Limited 2022 Q3 - Results - Earnings Call Presentation (NYSE:TEVA) | Seeking Alpha
TEVA PHARMACEUTICAL INDUSTRIES LIMITED : Historical Intraday Market Prices | TEVA | US8816242098 | MarketScreener
Teva selects North Jersey site for its new North American headquarters. - Philadelphia Business Journal
DEF 14A
Teva: Definitely Undervalued (NYSE:TEVA) | Seeking Alpha
DEF 14A
Teva launches AJOVY for the treatment of migraine with the YpsoMate autoinjector from Ypsomed - Ypsomed - Group
Teva Pharmaceutical Stock: Gem Among Generic Pharma Companies (NYSE:TEVA) | Seeking Alpha
Teva Reports Fourth Quarter and Full Year 2021 Financial Results | Business Wire
Teva Canada Announces New Autoinjector for AJOVY® for the Preventive Treatment of Migraine in Adults
DEF 14A
TEVA Earnings Date 2023 | Teva Pharmaceutical Industries Earnings Forecast
Teva Pharm expects to start paying U.S. opioid settlement in 2023 - CEO | MarketScreener
TEVA PHARMACEUTICAL INDUSTRIES LTD (ADR) : Stock Price | US8816242098 | MarketScreener
Teva timeline: CEO says 20-25 manufacturing plants to close in next two years
Teva: This One Is Difficult (NYSE:TEVA) | Seeking Alpha
Teva jumps after Wall Street upgrades, analysts say stock 'too cheap to ignore'
Teva Pharmaceutical Industries Limited 2022 Q3 - Results - Earnings Call Presentation (NYSE:TEVA) | Seeking Alpha
